ArticleScience translational medicine2020

Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans.

Jennifer A Jenks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.